Literature DB >> 10803583

3,5-diiodo-L-thyronine regulates glucose-6-phosphate dehydrogenase activity in the rat.

A Lombardi1, L Beneduce, M Moreno, S Diano, V Colantuoni, M V Ursini, A Lanni, F Goglia.   

Abstract

Thyroid hormones influence the activity of lipogenic enzymes such as malic enzyme (ME) and glucose-6-phosphate dehydrogenase (G6PD). The effect of T3 on ME is exerted at the transcriptional level, but it is unclear if its effect on G6PD is also nuclear mediated. Furthermore, other iodothyronines that have been shown to possess biological activity (such as diiodothyronines) could contribute to this enzyme's regulation. In this study the effects of 3,5-diiodothyronine (T2) on the aforementioned enzymes were examined and compared with those of T3. Rats made hypothyroid by propylthiouracil and iopanoic acid treatment were used throughout. Enzyme activities were determined spectrophotometrically, and G6PD messenger RNA (mRNA) expression was analyzed by Northern blotting using a human G6PD complementary DNA probe. Injections of T2 to hypothyroid animals significantly enhanced the activity of both enzymes. The effect of T2 on ME was nuclear mediated and mimicked the effect of T3. The effects of T2 and T3 on G6PD differed. Injection of T3 into hypothyroid rats induced an increase in both enzyme activity and G6PD mRNA expression, indicating a nuclear-mediated effect. The effect of T2 on G6PD activity, on the other hand, was not nuclear mediated. The injection of T2 into hypothyroid animals did not change G6PD mRNA expression, and the strong increase in the enzyme's activity (from +70% to +300%) was unaffected by simultaneous injection of protein synthesis inhibitors. As the lowest dose of 1 microg T2/100 g BW affects G6PD activity 3-5 times more than the same dose of T3, these data provide the first evidence that T2 is a factor capable of regulating G6PD activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803583     DOI: 10.1210/endo.141.5.7449

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Changes of activity and kinetics of certain liver and heart enzymes of hypothyroid and T(3)-treated rats.

Authors:  Urszula Czyzewska; Adam Tylicki; Magdalena Siemieniuk; Slawomir Strumilo
Journal:  J Physiol Biochem       Date:  2012-01-25       Impact factor: 4.158

Review 2.  Control of energy metabolism by iodothyronines.

Authors:  A Lanni; M Moreno; A Lombardi; P de Lange; F Goglia
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

3.  Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T2?

Authors:  Maik Pietzner; Ina Lehmphul; Nele Friedrich; Claudia Schurmann; Till Ittermann; Marcus Dörr; Matthias Nauck; René Laqua; Uwe Völker; Georg Brabant; Henry Völzke; Josef Köhrle; Georg Homuth; Henri Wallaschofski
Journal:  Thyroid       Date:  2014-11-24       Impact factor: 6.568

4.  Changes in antioxidant status, protein concentration, acetylcholinesterase, (Na+,K+)-, and Mg2+ -ATPase activities in the brain of hyper- and hypothyroid adult rats.

Authors:  Haris Carageorgiou; Constantinos Pantos; Apostolos Zarros; Iordanis Mourouzis; Dennis Varonos; Dennis Cokkinos; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

5.  Urine Metabolomics by (1)H-NMR Spectroscopy Indicates Associations between Serum 3,5-T2 Concentrations and Intermediary Metabolism in Euthyroid Humans.

Authors:  Maik Pietzner; Georg Homuth; Kathrin Budde; Ina Lehmphul; Uwe Völker; Henry Völzke; Matthias Nauck; Josef Köhrle; Nele Friedrich
Journal:  Eur Thyroid J       Date:  2015-05-28

6.  Serum Thyrotropin Concentrations Are Not Associated with the Ankle-Brachial Index: Results from Three Population-Based Studies.

Authors:  Till Ittermann; Roberto Lorbeer; Daniel Tiller; Ina Lehmphul; Alexander Kluttig; Stephan B Felix; Karl Werdan; Karin Halina Greiser; Josef Köhrle; Henry Völzke; Marcus Dörr
Journal:  Eur Thyroid J       Date:  2015-05-27

7.  The redox imbalance and the reduction of contractile protein content in rat hearts administered with L-thyroxine and Doxorubicin.

Authors:  Agnieszka Korga; Jaroslaw Dudka; Franciszek Burdan; Justyna Sliwinska; Slawomir Mandziuk; Katarzyna Dawidek-Pietryka
Journal:  Oxid Med Cell Longev       Date:  2012-02-26       Impact factor: 6.543

8.  3,5 Diiodo-l-Thyronine (T₂) Promotes the Browning of White Adipose Tissue in High-Fat Diet-Induced Overweight Male Rats Housed at Thermoneutrality.

Authors:  Rosalba Senese; Federica Cioffi; Rita De Matteis; Giuseppe Petito; Pieter de Lange; Elena Silvestri; Assunta Lombardi; Maria Moreno; Fernando Goglia; Antonia Lanni
Journal:  Cells       Date:  2019-03-18       Impact factor: 6.600

9.  Intensification of doxorubicin-related oxidative stress in the heart by hypothyroidism is not related to the expression of cytochrome P450 NADPH-reductase and inducible nitric oxide synthase, as well as activity of xanthine oxidase.

Authors:  Jaroslaw Dudka; Franciszek Burdan; Agnieszka Korga; Magdalena Iwan; Barbara Madej-Czerwonka; Monika Cendrowska-Pinkosz; Agnieszka Korobowicz-Markiewicz; Barbara Jodlowska-Jedrych; Wlodzimierz Matysiak
Journal:  Oxid Med Cell Longev       Date:  2012-08-23       Impact factor: 6.543

10.  Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues.

Authors:  Alvaro Souto Padron; Ruy Andrade Louzada Neto; Thiago Urgal Pantaleão; Maria Carolina de Souza dos Santos; Renata Lopes Araujo; Bruno Moulin de Andrade; Monique da Silva Leandro; João Pedro Saar Werneck de Castro; Andrea Claudia Freitas Ferreira; Denise Pires de Carvalho
Journal:  J Endocrinol       Date:  2014-04-01       Impact factor: 4.286

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.